GC Biopharma Corp. (KRX:006280)
135,000
+1,800 (1.35%)
Nov 17, 2026, 3:30 PM KST
| Market Cap | 1.54T -3.2% |
| Revenue (ttm) | 1.96T +9.7% |
| Net Income | -49.90B |
| EPS | -4,372.28 |
| Shares Out | 11.41M |
| PE Ratio | n/a |
| Forward PE | 21.85 |
| Dividend | 1,500.00 (1.11%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 28,188 |
| Open | 132,900 |
| Previous Close | 133,200 |
| Day's Range | 132,300 - 136,800 |
| 52-Week Range | 105,900 - 183,800 |
| Beta | 0.58 |
| Analysts | Buy |
| Price Target | 192,250.00 (+42.41%) |
| Est. Earnings | Mar 18, 2027 |